Phage cocktail as well as screening method and application thereof

By using a rapid screening method to screen phage cocktail combinations, the problems of high time and money costs and resistance development in existing technologies are solved, achieving highly efficient antibacterial effects and safe application.

CN118909969APending Publication Date: 2024-11-08WUHAN GRENON BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410937589.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies require significant time and financial investment in screening phage cocktail combinations and can easily lead to bacterial resistance to phages, affecting treatment efficacy.

Method used

Rapid screening methods, including testing the lysis profile of target strains, screening for first-line phages, culturing phage-resistant mutants, testing second-line phages, and combining first-line and second-line phages to form a cocktail, can simulate resistance development in the natural environment and enhance treatment efficacy.

Benefits of technology

It effectively inhibits the growth of target strains, reduces resistance development, and improves lysis efficiency. The selected phage cocktail combination has a high lysis rate and broad application potential against Escherichia coli infection, and is safe and has no toxic side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909969A_ABST
    Figure CN118909969A_ABST
Patent Text Reader

Abstract

The invention provides a bacteriophage cocktail and a screening method and application thereof, the screening method of the bacteriophage cocktail comprises the following steps: S1, testing a splitting spectrum of a target strain, and screening out a first-line bacteriophage splitting the target strain; s2, co-culturing a target strain and the first-line bacteriophage screened in the step S1, and screening out an anti-bacteriophage mutant strain; s3, testing the cracking spectrum of the anti-bacteriophage mutant strain screened in the step S2, and screening out a second-line bacteriophage capable of cracking the anti-bacteriophage mutant strain; s4, combining the first-line bacteriophage screened in the step S1 and the second-line bacteriophage screened in the step S3 to obtain the bacteriophage cocktail. According to the rapid screening method, the appropriate bacteriophage can be rapidly screened out without genome sequencing and analysis of bacteriophage and bacteria and bacteriophage receptor analysis, the tedious analysis process and cost can be omitted, and the technical effect of rapidly screening out the appropriate bacteriophage cocktail is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of microbial technology, and in particular to a phage cocktail and a screening method and application thereof. Background Art

[0002] As a potential natural, green, safe and effective alternative to antibiotics, phages have great advantages due to their high host specificity. However, bacterial resistance to phages will also greatly reduce the lysis ability of phages, thereby affecting the effectiveness of phage therapy. In order to improve the effectiveness of phage therapy and prevent bacteria from developing resistance, phage cocktail combinations are now often used to combat target pathogens, with significant results. However, the selection of phage cocktail combinations often requires a large amount of analysis of the candidate phage genome, tail fiber protein structure, and receptor protein types on the surface of the target pathogen, which requires a great deal of time and money. Therefore, how to quickly and cost-effectively screen out phage cocktail combinations has potential value and has broad application prospects in the livestock and poultry industry, aquaculture, and medical fields. Summary of the invention

[0003] In view of this, the present invention proposes a method and application for rapidly screening a phage cocktail combination. The technical solution of the present invention is implemented as follows: On the one hand, the present invention provides a method for rapidly screening a phage cocktail, comprising the following steps:

[0004] S1, test the lysis spectrum of the target strain and screen out the first-line phages that lyse the target strain; these phages are initial candidates for further screening and combination; the purpose of this is to determine which phages have lytic activity against the target strain as a basis for subsequent steps.

[0005] S2, co-culturing the target strain and the first-line phage screened in step S1 to screen out phage-resistant mutants; co-culturing the target strain with the screened first-line phage can naturally select some mutant strains that are resistant to these phages; under the pressure of the phage, some strains will mutate and develop resistance, thereby simulating the anti-phage phenomenon that may occur in the natural environment.

[0006] S3, testing the lysis spectrum of the phage-resistant mutant strain screened in step S2, and screening out second-line phages that can lyse the phage-resistant mutant strains; this process ensures that additional phages that can combat phage resistance are found, further enhancing the therapeutic effect.

[0007] S4, combining the first-line phage screened in step S1 and the second-line phage screened in step S3 to obtain a phage cocktail. This combined phage cocktail can more effectively inhibit the growth of the target strain and reduce the resistance of the target strain to phages, and improve the lysis efficiency in clinical applications through the synergistic effect of multiple phages.

[0008] The above method can effectively identify phages that cover the target strain and its resistant mutants, slow down or avoid the generation of anti-phage resistance, and enhance the ability to lyse clinical strains, thereby achieving a highly efficient antibacterial effect.

[0009] Specifically, the phage cocktail combination screened by the present invention can effectively inhibit the growth of the target strain, avoid the generation of phage resistance of the target strain, and has a high lysis rate for clinical strains.

[0010] On the basis of the above technical scheme, preferably, the target strain is one of Escherichia coli GRNDC8, Escherichia coli GRNSH48 and Escherichia coli GRNGXE1.

[0011] On the other hand, the present invention also provides a phage cocktail, which is screened by the above method.

[0012] On the other hand, the present invention also provides a use of a phage cocktail in preparing a drug for preventing and treating animal Escherichia coli disease.

[0013] Based on the above technical solution, preferably, the phage cocktail is in the form of powder, aqueous solution or paste.

[0014] On the other hand, the present invention also provides an application of a phage cocktail in a feed additive.

[0015] Based on the above technical solution, preferably, the concentration of each bacteriophage in the feed is ≥3.2×10 8 PFU / g, used to prevent or treat animal Escherichia coli disease.

[0016] On the other hand, the present invention also provides an application of a phage cocktail in disinfection of a farm environment.

[0017] Based on the above technical solution, preferably, the concentration of each bacteriophage in the disinfectant is ≥3.2×10 8 PFU / mL, by spray disinfection, the proliferation of E. coli in the breeding environment is inhibited to prevent the occurrence of animal E. coli disease.

[0018] The rapid screening method and application of a phage cocktail of the present invention has the following beneficial effects compared with the prior art:

[0019] (1) The rapid screening method of the present invention does not require phage and bacterial genome sequencing and analysis, and does not require phage receptor analysis, and can quickly screen out suitable phages, thereby eliminating cumbersome analysis procedures and costs, and achieving the technical effect of quickly screening out suitable phage cocktails.

[0020] (2) The phage composition selected by the rapid screening method provided by the present invention has a better antibacterial effect than a single phage strain and is not prone to produce phage resistance. It can be used for the prevention and treatment of Escherichia coli disease and has broad application potential.

[0021] (3) The present invention screened out first- and second-line phages for Escherichia coli GRNDC8, GRNSH48 and GRNGXE1, and grouped the phages in the library according to the changes before and after the lysis spectrum. One phage was selected from each group to form a cocktail. After that, when facing newly isolated clinical strains, it is no longer necessary to induce and screen first- and second-line phages. Direct use of this cocktail combination is basically effective. Experiments have shown that the lysis rate of this combination for clinical isolates is as high as 92%, and the effect is significant.

[0022] (4) The bacteriophage screened by the present invention against Escherichia coli is safe and has no toxic side effects, can be used to prevent or treat Escherichia coli disease, and can also be used as a feed additive and for disinfection and sterilization of breeding sites. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0024] Figure 1 This is a flow chart of a rapid screening method for an Escherichia coli phage cocktail of the present invention;

[0025] Figure 2 This is a comparison of the bactericidal ability of E. coli phage GDCP555 and E. coli cocktail combination against GRNDC8;

[0026] Figure 3 This is a comparison of the bactericidal ability of E. coli phage GDCP484 and E. coli cocktail combination against GRNSH48;

[0027] Figure 4 This is a comparison of the bactericidal ability of Escherichia coli phage GDCP421 and Escherichia coli cocktail combination against GRNGXE1. DETAILED DESCRIPTION

[0028] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0029] The formula of the TSB liquid culture medium used in the present invention is: 17g of casein pancreatic digest, 3g of soy flour papain digest, 5g of sodium chloride, 2.5g of dipotassium hydrogen phosphate, 2.5g of glucose, 1000mL of purified water, pH 7.3±0.2, and it is used after being sterilized by pressure steam at 121°C.

[0030] The formula of the TSB semi-solid culture medium used in the present invention is: 17g of casein pancreatic digest, 3g of soy flour papain digest, 5g of sodium chloride, 2.5g of dipotassium hydrogen phosphate, 2.5g of glucose, 7.5g of agar, 1000mL of purified water, pH 7.3±0.2, and it is used after being sterilized by pressure steam at 121°C.

[0031] Example 1

[0032] This example is used to screen a phage cocktail combination against Escherichia coli GRNDC8 isolated from a Shandong farm. The screening steps are as follows:

[0033] S1, the first-line lysis spectrum of Escherichia coli GRNDC8 was determined, and 50 strains of Escherichia coli phage were determined. The specific experimental method was the drop method: 100 μL of overnight cultured bacterial solution was added to the semi-solid culture medium, and after shaking and mixing, it was poured onto the nutrient agar plate culture medium to make it a double-layer culture medium. After the culture medium solidified, 5 μL of phage suspension was dropped on the culture medium, cultured overnight at 37°C, and observed whether there was a phage circle formed. The results are shown in Table 1. 18 phages can lyse the target strain Escherichia coli GRNDC8, among which the Escherichia coli phage GDCP555 has a good lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP555 was selected as the first-line phage.

[0034] S2, E. coli GRNDC8 was induced by taking 200 μL of overnight cultured E. coli GRNDC8 and the infection multiplicity was 0.01 (4×10 6 The phage GDCP555 with 100 PFU was added to 8 mL of LB liquid culture medium and cultured for 18-20 hours. When the culture medium changed from clear to turbid, then to clear, and finally to turbid again, the liquid culture was streaked on an LB plate to obtain a phage-resistant GRNDC8 mutant strain (GRNDC8 GDCP555R strain).

[0035] S3, the lysis spectrum of the mutant strain of antagonistic phage GDCP555 (GRNDC8 GDCP555R strain) was determined (second-line lysis spectrum), and 50 strains of Escherichia coli phage were determined. The specific experimental method was the same-line lysis spectrum determination, and the drop method was used on a double-layer agar plate. The results are shown in Table 2. The GRNDC8 GDCP555R strain showed a completely different lysis spectrum from the original strain Escherichia coli GRNDC8. 9 phages could lyse the GRNDC8 GDCP555R strain, among which the Escherichia coli phage GDCP179 had the best lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP179 was selected as the second-line phage.

[0036] S4, the first-line and second-line phages (GDCP555 and GDCP179) were used to form an E. coli cocktail combination to test its ability to lyse the original strain of E. coli GRNDC8. The experimental method was as follows: E. coli GRNDC8 was cultured in 200 mL LB liquid medium and diluted to OD 600 0.01(1×10 8 CFU / mL), 2×10 8 First-line phage GDCP555 and first-line and second-line phage combination (GDCP555 plus GDCP179) with a volume of 100 μL PFU (MOI of 0.01) were added to the host bacterial solution, and the control group was added with an equal volume of SM buffer. The culture was cultured at 37°C and 250 rpm for 16 hours, and the OD of the culture solution was tested at intervals of 30 minutes. 600 This experiment was performed in triplicate and the average value was calculated, and the growth curve of the strain was plotted.

[0037] The results are as follows Figure 2 As shown, the combination of first- and second-line phages could inhibit the growth of E. coli GRNDC8 for more than 24 hours, reducing its OD 600 The value was as low as 0.16, while the single phage GDCP555 could only inhibit E. coli GRNDC8 for 15 hours, and then the OD 600 The value reversed and rose to 1.10, indicating the development of phage resistance.

[0038] Example 2

[0039] This example is used to screen a phage cocktail combination against Escherichia coli GRNSH48 isolated from a breeding farm in Guangxi. The screening steps are the same as those in Example 1, as follows:

[0040] S1, the first-line lysis spectrum of E. coli GRNSH48 was determined, and 50 E. coli phages were determined. The results are shown in Table 1. 19 phages can lyse the target strain E. coli GRNSH48, among which the E. coli phage GDCP484 has the best lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP484 was selected as the first-line phage.

[0041] S2, induce Escherichia coli GRNSH48 to obtain the phage-resistant GRNSH48 mutant strain (GRNSH48GDCP484R strain).

[0042] S3, the lysis spectrum of the mutant strain (GRNSH48 GDCP484R strain) against the phage GDCP484 was determined (second-line lysis spectrum), and 50 strains of E. coli phage were determined. The results are shown in Table 2. The GRNSH48GDCP484R strain showed a completely different lysis spectrum from the original strain E. coli GRNSH48. 10 phages could lyse the GRNSH48 GDCP484R strain, among which the E. coli phage GDCP356 had the best lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP356 was selected as the second-line phage.

[0043] S4, the first-line and second-line phages (GDCP484 and GDCP356) were used to form an E. coli cocktail combination to test its ability to lyse the original strain of E. coli GRNSH48. The experimental method was as follows: E. coli GRNSH48 was cultured in 200 mL LB liquid medium and diluted to OD 600 0.01(1.6×10 8 CFU / mL), 3.2×10 8 First-line phage GDCP484 and first-line and second-line phage combination (GDCP484 plus GDCP356) with a volume of 100 μL PFU (MOI of 0.01) were added to the host bacterial solution, and the control group was added with an equal volume of SM buffer. The culture was cultured at 37°C and 250 rpm for 16 hours, and the OD of the culture solution was tested at intervals of 30 minutes. 600 This experiment was performed in triplicate and the average value was calculated, and the growth curve of the strain was plotted.

[0044] The results are as follows Figure 3 As shown, the combination of first-line and second-line phages could inhibit the growth of E. coli GRNSH48 during 24 hours, making its OD 600 The value was as low as 0.13, while a single phage GDCP484 could only inhibit E. coli GRNSH48 for 14 hours, and the OD 600 The lowest value reached 0.31, and then OD 600The value reversed and rose, indicating that there were phage-resistant mutants.

[0045] Example 3

[0046] This example is used to screen a phage cocktail combination against Escherichia coli GRNGXE1 isolated from a breeding farm in Guangdong. The steps are the same as those in Example 1 and Example 2. The screening method is as follows:

[0047] S1, the first-line lysis spectrum of E. coli GRNGXE1 was determined, and 50 E. coli phages were determined. The results are shown in Table 1. Two phages can lyse the target strain E. coli GRNGXE1, among which the E. coli phage GDCP421 has the best lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP421 was selected as the first-line phage.

[0048] S2, inducing Escherichia coli GRNGXE1 to obtain a phage GDCP421-resistant mutant strain (GRNGXE1GDCP421R strain).

[0049] S3, the lysis spectrum of the mutant strain (GRNGXE1 GDCP421R strain) against the phage GDCP421 was determined (second-line lysis spectrum), and 50 strains of E. coli phage were determined. The results are shown in Table 2. The lysis spectrum of the GRNGXE1GDCP421R strain is completely different from that of the original strain E. coli GRNGXE1. 12 strains of phage can lyse the GRNGXE1 GDCP421R strain, among which the E. coli phage GDCP284 has the best lysis effect, showing a transparent and large phage circle on the bacterial lawn, so phage GDCP284 was selected as the second-line phage.

[0050] S4, the first-line and second-line phages (GDCP421 and GDCP284) were used to form an E. coli cocktail combination to test its ability to lyse the original strain of E. coli GRNGXE1. The experimental method was as follows: E. coli GRNGXE1 was cultured in 200 mL LB liquid medium and diluted to OD 600 0.01(1.5×10 8 CFU / mL), 3.0×10 8 First-line phage GDCP421 and first-line and second-line phage combination (GDCP421 plus GDCP284) with a volume of 100 μL PFU (MOI of 0.01) were added to the host bacterial solution, and the control group was added with an equal volume of SM buffer. The culture was cultured at 37°C and 250 rpm for 16 hours, and the OD of the culture solution was tested at intervals of 30 minutes. 600 This experiment was performed in triplicate and the average value was calculated, and the growth curve of the strain was plotted.

[0051] The results are as follows Figure 4 As shown, the combination of first-line and second-line phages could inhibit the growth of E. coli GRNGXE1 during 24 hours, making its OD 600 The value was as low as 0.16, while the single phage GDCP421 could only inhibit E. coli GRNGXE1 to a limited extent, OD 600 The value drops to 0.43 and then stops decreasing.

[0052] Table 1 Cleavage spectra of E. coli GRNDC8, GRNSH48 and GRNGXE1

[0053]

[0054]

[0055] Table 2 Cleavage spectra of E. coli induced mutants GRNDC8 GDCP555R, GRNSH48 GDCP484R and GRNGXE1GDCP421R

[0056]

[0057] Example 4

[0058] Phage grouping: After screening the first- and second-line phages, the phages can be grouped according to the changes in the lysis spectrum, as shown in Table 3. From the pattern of changes in the lysis spectrum, it can be inferred which phages recognize the same receptor and which recognize different receptors. Therefore, the phages can be divided into three groups: GDCP267, GDCP281, and GDCP484 are one group; GDCP106, GDCP378, and GDCP399 are two groups; GDCP223 and GDCP421 are three groups.

[0059] Table 3 Changes in lysis spectra and phage grouping of the original strain and induced mutant strains of E. coli

[0060]

[0061] Therefore, in this embodiment, one phage strain is directly selected from each of the first, second and third groups to form a cocktail combination. The cocktail combination consists of the following components: cocktail combination 1: GDCP267, GDCP106 and GDCP223; cocktail combination 2: GDCP281, GDCP378 and GDCP421.

[0062] The lysis rate of the clinical isolated strains was determined by the cocktail combination, and the specific experimental method was the drip method. The results are shown in Table 4. The rapid screening cocktail combination had a lysis rate of 92% for clinical strains. The high lysis rate can solve most clinical infections.

[0063] Table 4 Lysis rate of cocktail combination 1 and cocktail combination 2 against clinical isolated strains

[0064]

[0065]

[0066] Examples 1-3 screened out first- and second-line phages for the three strains of GRNDC8, GRNSH48 and GRNGXE1. Example 4 grouped the phages in the library according to the changes before and after the lysis spectrum, and selected one phage from each group to form a cocktail. After that, when facing newly isolated clinical strains, there was no need to induce and screen first- and second-line phages. Direct use of this cocktail combination was basically effective. The lysis rate of this combination against clinical isolates was as high as 92%.

[0067] Safety test of phage cocktail: 48 chicks of about 2 weeks old were selected and randomly divided into 6 groups, 8 in each of Examples 1 to 3 and Example 4 Cocktail combination 1 and Cocktail combination 2, and 8 in the control group. Examples 1 to 2 were injected, and Examples 3 to 4 were gavage. The control group had 4 chicks injected with 1 mL of sterile saline, and 4 chicks gavage with 1 mL of sterile saline. The injection volume was 3.2×10 8 PFU / mL, a total of 1 mL was injected; the oral dose was 3.2×10 8 PFU / mL, 1mL was injected in total. The six groups of chicks were raised under the same environmental conditions for two weeks, and clinical changes were observed. The results showed that all six groups of chicks grew well during the raising period, without diarrhea or death, indicating that the phage cocktail composition screened by this method is safe and has no toxic side effects.

[0068] Effect of phage cocktail on prevention and control of Escherichia coli disease in chickens: 50 chickens about 2 weeks old were selected and randomly divided into 5 groups, 10 chickens in each of Examples 1 to 3 and Cocktail combination 1 and Cocktail combination 2 of Example 4, and the concentration of Escherichia coli was 3.2×10 8 CFU / mL was used for virus attack, and when 50% of the chickens showed symptoms of diarrhea, loss of appetite and lack of energy, phage cocktail treatment was started. After continuous medication for 5 days, the deaths were observed for 2 weeks. The results showed that the cure rates of Examples 1 to 4 were all above 95%, indicating that the phages screened by the method of the present invention have a preventive and control effect on E. coli disease in chicks, and can be made into powder and mixed with feed to prevent and control E. coli disease.

[0069] Application of bacteriophage cocktail in farm environmental disinfectant: A disinfection test was conducted on the chicken farm environment. Bacteriophage and water were mixed at a ratio of 1:500 and then sprayed at a spray volume of 20mL / m 3, the count of E. coli in the air was collected by natural sedimentation method 30 minutes after spraying. The results showed that the phage cocktail combinations of Examples 1 to 4 all had strong killing power against E. coli, and the killing rate reached more than 95%, proving that the phage cocktail combination screened by the present invention had obvious antiviral effect on E. coli when used in chicken farm disinfection spray.

[0070] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A rapid screening method for phage cocktail, characterized in that: The following steps are involved: S1, test the lysis spectrum of the target strain and screen out the first-line phage that lyses the target strain; S2, co-culturing the target strain and the first-line phage screened in step S1 to screen out phage-resistant mutants; S3, testing the lysis spectrum of the phage-resistant mutant strain screened in step S2, and screening out the second-line phage that can lyse the phage-resistant mutant strain; S4, combining the first-line phage screened in step S1 and the second-line phage screened in step S3 to obtain a phage cocktail.

2. A phage cocktail, characterized in that: The phage cocktail is obtained by screening the method according to claim 1.

3. Use of a phage cocktail as claimed in claim 2 in the preparation of a drug for preventing and treating Escherichia coli disease in animals.

4. Use of a phage cocktail as claimed in claim 3 in the preparation of a drug for preventing and treating animal Escherichia coli disease, characterized in that: The target strain is one of Escherichia coli GRNDC8, Escherichia coli GRNSH48 and Escherichia coli GRNGXE1.

5. Use of a phage cocktail as claimed in claim 3 in the preparation of a drug for preventing and treating Escherichia coli disease in animals, characterized in that: The phage cocktail is in the form of powder, liquid or paste.

6. Use of a phage cocktail as claimed in claim 2 in a feed additive.

7. The use of a phage cocktail in a feed additive as claimed in claim 6, characterized in that: The concentration of each bacteriophage in the feed is ≥3.2×10 8 PFU / g.

8. Use of a phage cocktail as claimed in claim 2 in disinfection of farm environment.

9. The use of a phage cocktail as claimed in claim 8 in a farm environmental disinfectant, characterized in that: The concentration of each bacteriophage in the disinfectant is ≥ 3.2×10 8 PFU / mL.